Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

NCT05136222 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 244

Last updated 2022-06-23

No results posted yet for this study

Summary

A two-arm, individual participant randomised controlled, assessor-blinded trial in 7 MND care centres across Australia will be undertaken.

Conditions

  • Motor Neuron Disease / Amyotrophic Lateral Sclerosis

Interventions

OTHER

Intervention polysomnography

Please refer to 'Arms: Intervention' section.

OTHER

Sham polysomnography

Please refer to 'Arms: Control' section.

Sponsors & Collaborators

  • Austin Hospital, Melbourne Australia

    collaborator OTHER
  • Institute for Breathing and Sleep, Australia

    collaborator OTHER
  • Royal Prince Alfred Hospital, Sydney, Australia

    collaborator OTHER
  • Macquarie University, Australia

    collaborator OTHER
  • Macquarie Health

    collaborator UNKNOWN
  • Western Sydney Local Health District

    collaborator OTHER
  • Flinders Medical Centre

    collaborator OTHER_GOV
  • Sir Charles Gairdner Hospital

    collaborator OTHER
  • The Prince Charles Hospital

    collaborator OTHER_GOV
  • Monash University

    collaborator OTHER
  • Motor Neurone Disease Australia

    collaborator UNKNOWN
  • FightMND

    collaborator OTHER
  • Australian Motor Neurone Disease Registry

    collaborator UNKNOWN
  • Calvary Bethlehem

    collaborator UNKNOWN
  • Perron Institute for Neurological and Translational Science

    collaborator OTHER
  • University of Melbourne

    lead OTHER

Principal Investigators

  • Abbey Sawyer, PhD · University of Melbourne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2026-02-28
Completion
2028-02-28

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05136222 on ClinicalTrials.gov